Skip to content

Lung protective effect of dexmedetomidine combined with protective lung ventilation in one-lung ventilation

Lung protective effect of dexmedetomidine combined with protective lung ventilation in one-lung ventilation

Status
Recruiting
Phases
Phase 4
Study type
Interventional
Source
ChiCTR
Registry ID
ChiCTR2000041525
Enrollment
Unknown
Registered
2020-12-27
Start date
2021-01-01
Completion date
Unknown
Last updated
2021-03-15

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Lung protection

Interventions

Group B:Protective lung ventilation
Group C:Protective lung ventilation + dexmedetomidine 0.50 ug·kg-1·h-1
Group D:Protective lung ventilation + dexmedetomidine 0.80 ug·kg-1·h-1

Sponsors

Department of Anesthesiology, Shiyan People's Hospital
Lead Sponsor

Eligibility

Sex/Gender
All
Age
40 Years to 70 Years

Inclusion criteria

Inclusion criteria: 1. Patients who meet the operation indications and anesthesia requirements; 2. All patients signed informed consent; 3. Approved by the ethics committee of the college; 4. Subjects with normal preoperative pulmonary function test results.

Exclusion criteria

Exclusion criteria: 1. Patients with history of mental illness and nervous system diseases; 2. Patients with severe heart, lung, liver and kidney diseases; 3. Patients with thoracic and spinal deformities; 4. Subjects with long-term smoking history.

Design outcomes

Primary

MeasureTime frame
Alveolar arterial oxygen partial pressure;Arterial partial pressure of oxygen;Oxygenation index;Respiratory index;Intrapulmonary shunt rate;Peak airway pressure;Mean airway pressure;Nitric oxide;Postoperative complications;Postoperative hospital stay;

Countries

China

Contacts

Public ContactZheng Min

Graduate School of Hubei Medical College

lhj1286@163.com+86 13872767699

Outcome results

None listed

Source: ChiCTR (via WHO ICTRP) · Data processed: Feb 4, 2026